unknown
Stage
2020
Founded
2
Investors
About
Frontera Therapeutics is a clinical-stage gene therapy company that develops AAV-based gene therapies using its EXACTE capsid and transgene engineering platform. Its pipeline includes programs targeting inherited retinal diseases (e.g., RPE65 and XLRP) and it operates internationally (US and China presence).
Explore Frontera Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.